GBT
Global Blood Therapeutics Inc
Price:  
68.49 
USD
Volume:  
3,279,960.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GBT Relative Valuation

-244.4%
Upside

As of 2025-06-22, the Relative Valuation of Global Blood Therapeutics Inc (GBT) is (98.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.49 USD, the upside of Global Blood Therapeutics Inc based on Relative Valuation is -244.4%.

The range of the Relative Valuation is (78.85) - (111.83) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 15.0x - 23.4x 19.2x
Forward P/E multiples 16.5x - 27.9x 22.2x
Fair Price (78.85) - (111.83) (98.92)
Upside -215.1% - -263.3% -244.4%
68.49 USD
Stock Price
(98.92) USD
Fair Price

GBT Relative Valuation - Historical P/E Data

Date P/E